Tissue-marking scheme for a cost-effective extended prostate biopsy protocol

Urologic Oncology: Seminars and Original Investigations

Volumn 27, Issue 1, 2009, Pages 21-25

  Firoozi, Farzeen ^a   Nazeer, Tipu ^a   Fisher, Hugh A G ^a   Kaufman Jr , Ronald P ^a   White, Mark D ^a   Mian, Badar M ^a  

^a STRATTON VA MEDICAL CENTER   (United States)

Author keywords

Biopsy; Cost analysis; Detection; Prognosis; Prostate cancer

Indexed keywords

ADULT; ARTICLE; COST EFFECTIVENESS ANALYSIS; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY;

AGED; BIOPSY; COST-BENEFIT ANALYSIS; COSTS AND COST ANALYSIS; HUMANS; MALE; MEDICAL ONCOLOGY; MIDDLE AGED; PROGNOSIS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RESEARCH DESIGN;

EID: 57849122471     PISSN: 10781439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urolonc.2007.09.002     Document Type: Article

References (20)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2006. CA Cancer J Clin 56 (2006) 106-130
2. Babaian R.J., Toi A., Kamoi K., et al. A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy. J Urol 163 (2000) 152-157
3. Presti Jr. J.C., O'Dowd G.J., Miller M.C., et al. Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study. J Urol 169 (2003) 125-129
4. Malavaud B., Villers A., Ravery V., et al. Role of preoperative positive apical biopsies in the prediction of specimen-confined prostate cancer after radical retropubic prostatectomy: a multi-institutional study. Eur Urol 37 (2000) 281-288
5. Mian B.M., Lehr D.J., Moore C.K., et al. Role of prostate biopsy schemes in accurate prediction of Gleason scores. Urology 67 (2006) 379-383
6. Kamat A.M., Jacobsohn K.M., Troncoso P., et al. Validation of criteria used to predict extraprostatic cancer extension: A tool for use in selecting patients for nerve sparing radical prostatectomy. J Urol 174 (2005) 1262-1265
7. Naya Y., Slaton J.W., Troncoso P., et al. Tumor length and location of cancer on biopsy predict for side specific extraprostatic cancer extension. J Urol 171 (2004) 1093-1097
8. Gao X., Mohideen N., Flanigan R.C., et al. The extent of biopsy involvement as an independent predictor of extraprostatic extension and surgical margin status in low risk prostate cancer: implications for treatment selection. J Urol 164 (2000) 1982-1986
9. Brat D.J., Wills M.L., Lecksell K.L., et al. How often are diagnostic features missed with less extensive histologic sampling of prostate needle biopsy specimens?. Am J Surg Pathol 23 (1999) 257-262
10. Kao J., Upton M., Zhang P., et al. Individual prostate biopsy core embedding facilitates maximal tissue representation. J Urol 168 (2002) 496-499
11. Terris M.K., and McNeal J.E. Application of tissue-marking ink to prostate biopsy specimens. Prostate 50 (2002) 247-251
12. Babaian R.J. Extended field prostate biopsy enhances cancer detection. Urology 55 (2000) 453-456
13. Elliott S.P., Shinohara K., Logan S.L., et al. Sextant prostate biopsies predict side and sextant site of extracapsular extension of prostate cancer. J Urol 168 (2002) 105-109
14. Epstein J.I., Carmichael M.J., Pizov G., et al. Influence of capsular penetration on progression following radical prostatectomy: A study of 196 cases with long-term followup. J Urol 150 (1993) 135-141
15. Cheng L., Darson M.F., Bergstralh E.J., et al. Correlation of margin status and extraprostatic extension with progression of prostate carcinoma. Cancer 86 (1999) 1775-1782
16. Descazeaud A., Rubin M.A., Allory Y., et al. What information are urologists extracting from prostate needle biopsy reports and what do they need for clinical management of prostate cancer?. Eur Urol 48 (2005) 911-915
17. Taneja S.S., Penson D.F., Epelbaum A., et al. Does site specific labeling of sextant biopsy cores predict the site of extracapsular extension in radical prostatectomy surgical specimen?. J Urol 162 (1999) 1352-1357 Discussion 1357-8
18. Tsuzuki T., Hernandez D.J., Aydin H., et al. Prediction of extraprostatic extension in the neurovascular bundle based on prostate needle biopsy pathology, serum prostate specific antigen, and digital rectal examination. J Urol 173 (2005) 450-453
19. Ohori M., Kattan M.W., Koh H., et al. Predicting the presence and side of extracapsular extension: A nomogram for staging prostate cancer. J Urol 171 (2004) 1844-1849 Discussion 1849
20. Gancarczyk K.J., Wu H., McLeod D.G., et al. Using the percentage of biopsy cores positive for cancer, pretreatment PSA, and highest biopsy Gleason sum to predict pathologic stage after radical prostatectomy: The Center for Prostate Disease Research nomograms. Urology 61 (2003) 589-595